Phillips 66 (PSX) Hits Fresh High: Is There Still Room to Run?

Phillips 66 gained 8.9% over the past month and reached a 52-week high of $282.64; its shares are up 118.2% year to date. The company reported last-quarter EPS of $9.41 versus a $7.68 consensus and has beaten earnings estimates in each of the past four quarters. Zacks assigns PSX a #1 Strong Buy rank, though its 9.7x forward P/E and 19.1x trailing cash-flow multiple exceed peer averages of 8.9x and 12x, respectively.

Analysis

The key issue is earnings durability, not the recent breakout: the supplied estimates imply little EPS growth next year despite lower revenue, suggesting current earnings power may be unusually strong or the estimate base is vulnerable. Refining earnings can turn quickly with crack spreads, feedstock discounts, utilization and unplanned outages; a modest normalization could compress both EPS and the multiple. PSX’s premium to the cited industry P/E and cash-flow multiple leaves less valuation cushion after the sharp rerating. Its broader midstream/chemicals exposure may soften a refining downturn, but segment-level earnings and cash conversion are needed to quantify that protection.

PBF is not an obvious substitute long: its low forward P/E may reflect greater sensitivity to refining-cycle earnings, while the cited 55.51x cash-flow multiple is a warning to verify cash-flow definitions and period alignment before treating it as cheap. Near term, estimate revisions and the next results can sustain momentum; over 1–3 months, crack-spread direction and guidance quality matter more than another headline EPS beat. Over 6–18 months, normalization is the central downside risk. Contrarian view: the industry tailwind may be real, but extrapolating peak-cycle EPS from surprise history risks buying earnings rather than durable cash generation.

Key Decisions for Investors

• Do not chase PSX solely on momentum or the Strong Buy label. For existing exposure, consider trimming into strength or using a defined-risk put spread rather than an outright short; the stock can keep rallying if estimates continue upward.
• Keep a conditional PSX-vs-PBF relative-value watch, not an immediate pair trade: require comparable forward cash-flow definitions, leverage and segment exposure first. PBF’s low stated P/E alone is not evidence of cheaper normalized earnings.
• Before adding, verify PSX segment earnings, operating cash flow versus reported EPS, analyst estimate revisions, and current refining crack spreads. Favor entry after a pullback or after results confirm cash conversion and next-year earnings resilience.
• Falsify the cautious thesis if PSX sustains upward estimate revisions while cash conversion remains strong and refining indicators hold; strengthen it if spreads weaken, guidance is cut, or cash flow materially lags earnings.